Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
1
33%
Ph phase_4
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Completed1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 42 (66.7%)

Trials by Status

completed133%
recruiting133%
not_yet_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruitingphase_4

Combating Related Epidemics in HCV

NCT07560046
recruitingphase_4

Implementing Low-Barrier HCV Treatment in a Jail Setting

NCT06953479
completedphase_2

Utilization of Hepatitis C Positive Kidneys in Negative Recipients

NCT03801707

Clinical Trials (3)

Showing 3 of 3 trials
NCT07560046Phase 4

Combating Related Epidemics in HCV

Not Yet Recruiting
NCT06953479Phase 4

Implementing Low-Barrier HCV Treatment in a Jail Setting

Recruiting
NCT03801707Phase 2

Utilization of Hepatitis C Positive Kidneys in Negative Recipients

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3